The editorial published in Lancet Infectious Diseases October 14th 2021, reviews this issue. There has been widespread coverage in the media of Merck and Ridgeback’s interim results of their phase 2 trial of the antiviral molnupiravir. According to a press...
People who are fully vaccinated against COVID-19 appear to have a much lower likelihood of developing Long COVID than in the unvaccinated group. This research published by Antonelli and others in The Lancet Infectious Diseases 1st September is amongst the...
Kalil and Stebbing published their data in The Lancet Respiratory Medicine on 1st September. Antibacterial, antifungal, antiviral, and antiparasitic treatments developed in the past century have improved survival outcomes, even in high-mortality conditions such as...
The editorial published in The Lancet August 28th 2021 reviews this. As the COVID-19 pandemic continues, the need to understand and respond to long COVID is increasingly pressing. Symptoms such as persistent fatigue, breathlessness, brain fog and depression could...
Huang and others published this study in The Lancet August 28th 2021. The full range of long term health consequences of COVID-19 in patients who are discharged from hospital is largely unclear. The aim of this study was to comprehensively compare...
An interesting paper published in the BMJ by Takeshita and others researched this issue. Although several studies have reported an association between atherosclerotic related diseases and COVID-19, the relationship between COVID-19 severity and...
